Further information AstraZeneca
FURTHER INFORMATION REGARDING THE MERGER BETWEEN ASTRA AND ZENECA The stock exchanges in Stockholm, London and New York have now approved the documentation regarding the merger between Astra and the British bioscience company Zeneca. The international prospectus will be made available at Astra AB, PR & Information, Södertälje, and at Enskilda Securities, Nybrokajen 5, Stockholm. In this connection, Astra will start distributing the prospectus. Between January 25 and March 18, 1999, Astra shareholders can exchange their shares in Astra for new shares in AstraZeneca, which will be one of the
